To Request A Free Sample Copy Of This Report, Please Click Below Link https://www.inkwoodresearch.com/reports/ophthalmic-drugs -market-forecast-2017-2024
Ophthalmic Drugs Market Global Market Trends, Analysis & Outlook 2017-2024 www.inkwoodresearch.com
Report Summary • The global ophthalmic drugs market is estimated to grow at an approximate CAGR of 7.86% during the period of 2017 and 2024. • An existing predominance and increase in the number of eye disorders with growing geriatric population all over the world are the primary drivers responsible for the market growth. • With increasing awareness of ophthalmic drugs among the consumers and patients is anticipated to proliferate the market growth.
Market Insights • The ophthalmic drugs market is segmented on the basis of End-user, Prescription type, and Geography. • The Prescription type ophthalmic drugs market is segregated into Prescription Market for Ophthalmic Drugs and OTC (Over the Counter Drugs) Market for Ophthalmic Drugs. • The End-user ophthalmic drugs market is segregated into Hospitals, Eye Clinics, Diagnostic Centers, and Patients. The ophthalmic drugs market on the basis of Geography is segregated into Asia-Pacific, Europe, North America, Middle East & Africa and Central & South America. • The technological advancements, rise in eye disorders, growth in geriatric population, cataract surgeries and upsurge in healthcare expenditure are dominant drivers for the growth of ophthalmic drugs market.
Market Insights • A vast scope for ophthalmic drugs market is created with the predominance of eye-related disorders and ailments. • One major cause for half-blindness and decreased vision is Cataract with the highest percentage accountable of worldwide visual impairment. • Cataract surgery is risk-free and secure kind of surgery; the safety has led to an increase in the cataract surgeries. • The boost in Health expenditure has boosted the consumer spending indirectly driving the ophthalmic drugs market.
Market Share
Competitive Insights The predominant ophthalmic drugs companies in the global market are Bayer, Akorn, Johnson and Johnson, Abbott Laboratories, Valeant, Allergan Inc., Regeneron, Merck & Co., Pfizer Inc., Lpath Incorporated, Novartis Ag, Roche Holding Ag, Eyegate Pharmaceuticals, GlaxoSmithKline, Santen Pharmaceutical Co. Ltd, Sun Pharmaceuticals Industries, Ltd., Senju Pharmaceutical Co., Ltd, Cipla Pharmaceuticals and EyeMed.
Report Segmentation GLOBAL OPHTHALMIC DRUGS MARKET BY PRESCRIPTION TYPE GLOBAL PRESCRIPTION MARKET FOR OPHTHALMIC DRUGS GLOBAL OTC (OVER THE COUNTER DRUGS) MARKET FOR OPHTHALMIC DRUGS GLOBAL OPHTHALMIC DRUGS MARKET BY END USER GLOBAL HOSPITALS OPHTHALMIC DRUGS MARKET GLOBAL EYE CLINICS OPHTHALMIC DRUGS MARKET GLOBAL DIAGNOSTIC CENTERS OPHTHALMIC DRUGS MARKET GLOBAL PATIENTS OPHTHALMIC DRUGS MARKET REGIONAL ANALYSISNORTH AMERICA UNITED STATES (U.S.) CANADA MEXICO
EUROPE GERMANY UNITED KINGDOM(UK) RUSSIA FRANCE ITALY SPAIN ASIA PACIFIC CHINA INDIA SOUTH KOREA JAPAN AUSTRALIA MIDDLE EAST & AFRICA CENTRAL &SOUTH AMERICA
Request a Free Sample To Request A Free Sample Copy Of This Report, Please Click The Link Below
https://www.inkwoodresearch.com/reports/ ophthalmic-drugs-market-forecast-2017-20 24
About Us
Inkwood Research specializes in syndicated research reports, customized research reports and consulting services. We offer market intelligence studies across a range of industries including Technology, Chemicals, Materials, Healthcare and Energy. With 20 years of research experience, we ensure you efficient deliverables with global and country industry knowledge and research expertise. Our analysis covers North & South America, Europe, CEE, CIS, Middle East, Africa and Asia.
Contact Us
169, Harrison Avenue Boston, MA 02111.
+1 857-302-4704 Sales@inkwoodresearch.com www.inkwoodresearch.com